A Call to Create Integrated Services to Better Address the Needs of Migrants Who Use Drugs in Europe

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2024 Jan 13

PMID 38218849

Authors

Lena van Selm

Trenton M White

Camila A Picchio

Ana Requena-Mendez

Machteld Busz

Roberto Perez Gayo

Aline Pouille

Pedro Mateu Gelabert

Jeffrey V Lazarus

Affiliations

Soon will be listed here.

Abstract

Each year, thousands of migrants enter the EU. Data on drug use in migrant populations are scarce and inconclusive. However, several risk factors make them particularly vulnerable to engaging in problematic drug use. In this perspective, we summarize the limited information that is available on migrants who use drugs and make a case as to why it is essential to improve access to health and social services, including harm reduction services, for this population. With this aim, we call for the co-creation of integrated services that better address the needs of migrants who use drugs in Europe.

Citing Articles

Challenges and support needs among persons with a migration background who use drugs in four European metropolitan cities.

Pouille A, De Ruysscher C, van Selm L, van Amsterdam J, van den Brink W, Busz M Harm Reduct J. 2024; 21(1):208.

PMID: 39580438 PMC: 11585216. DOI: 10.1186/s12954-024-01110-x.

References

Lazarus J, Baker L, Cascio M, Onyango D, Schatz E, Smith A . Novel health systems service design checklist to improve healthcare access for marginalised, underserved communities in Europe. BMJ Open. 2020; 10(4):e035621. PMC: 7170642. DOI: 10.1136/bmjopen-2019-035621. View

Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim A . Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023; 8(6):533-552. PMC: 10817215. DOI: 10.1016/S2468-1253(23)00018-3. View

Kirkinis K, Pieterse A, Martin C, Agiliga A, Brownell A . Racism, racial discrimination, and trauma: a systematic review of the social science literature. Ethn Health. 2018; 26(3):392-412. DOI: 10.1080/13557858.2018.1514453. View

van Selm L, White T, Picchio C, Requena-Mendez A, Busz M, Bakker I . Drug use and access to drug dependency services for vulnerable migrants who use drugs in the European Union: Consensus statements and recommendations from civil society experts in Europe. Int J Drug Policy. 2023; 118:104087. DOI: 10.1016/j.drugpo.2023.104087. View

Wilson D, Donald B, Shattock A, Wilson D, Fraser-Hurt N . The cost-effectiveness of harm reduction. Int J Drug Policy. 2015; 26 Suppl 1:S5-11. DOI: 10.1016/j.drugpo.2014.11.007. View

Kim S, Pulkki-Brannstrom A, Skordis-Worrall J . Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine. Cost Eff Resour Alloc. 2015; 12:25. PMC: 4396789. DOI: 10.1186/1478-7547-12-25. View

Paradies Y, Ben J, Denson N, Elias A, Priest N, Pieterse A . Racism as a Determinant of Health: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(9):e0138511. PMC: 4580597. DOI: 10.1371/journal.pone.0138511. View

Cousien A, Tran V, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin J . Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France. J Viral Hepat. 2018; 25(10):1197-1207. DOI: 10.1111/jvh.12919. View

Heath M, Hvass A, Wejse C . Interpreter services and effect on healthcare - a systematic review of the impact of different types of interpreters on patient outcome. J Migr Health. 2023; 7:100162. PMC: 9932446. DOI: 10.1016/j.jmh.2023.100162. View

10.

Vignier N, du Lou A, Pannetier J, Ravalihasy A, Gosselin A, Lert F . Access to health insurance coverage among sub-Saharan African migrants living in France: Results of the ANRS-PARCOURS study. PLoS One. 2018; 13(2):e0192916. PMC: 5814022. DOI: 10.1371/journal.pone.0192916. View

11.

Savage J, Mezuk B . Psychosocial and contextual determinants of alcohol and drug use disorders in the National Latino and Asian American Study. Drug Alcohol Depend. 2014; 139:71-8. PMC: 4117235. DOI: 10.1016/j.drugalcdep.2014.03.011. View

12.

Lobel L, Kroger H, Tibubos A . How Migration Status Shapes Susceptibility of Individuals' Loneliness to Social Isolation. Int J Public Health. 2022; 67:1604576. PMC: 9763294. DOI: 10.3389/ijph.2022.1604576. View

13.

Pettersen R, Debesay J . Substance use and help-seeking barriers: a qualitative study of East African migrants' experiences of access to Norwegian healthcare services. BMC Health Serv Res. 2023; 23(1):107. PMC: 9891897. DOI: 10.1186/s12913-023-09110-6. View

14.

MacFarlane A, Ogoro M, De Freitas C, Niranjan V, Severoni S, Waagensen E . Migrants' involvement in health policy, service development and research in the WHO European Region: A narrative review of policy and practice. Trop Med Int Health. 2021; 26(10):1164-1176. DOI: 10.1111/tmi.13643. View

15.

Pannetier J, Lert F, Roustide M, du Lou A . Mental health of sub-saharan african migrants: The gendered role of migration paths and transnational ties. SSM Popul Health. 2018; 3:549-557. PMC: 5769072. DOI: 10.1016/j.ssmph.2017.06.003. View

16.

Horyniak D, Melo J, Farrell R, Ojeda V, Strathdee S . Epidemiology of Substance Use among Forced Migrants: A Global Systematic Review. PLoS One. 2016; 11(7):e0159134. PMC: 4943736. DOI: 10.1371/journal.pone.0159134. View

17.

Lebano A, Hamed S, Bradby H, Gil-Salmeron A, Dura-Ferrandis E, Garces-Ferrer J . Migrants' and refugees' health status and healthcare in Europe: a scoping literature review. BMC Public Health. 2020; 20(1):1039. PMC: 7329528. DOI: 10.1186/s12889-020-08749-8. View

18.

Ti L, Tzemis D, Buxton J . Engaging people who use drugs in policy and program development: a review of the literature. Subst Abuse Treat Prev Policy. 2012; 7:47. PMC: 3551750. DOI: 10.1186/1747-597X-7-47. View